GEODE CAPITAL MANAGEMENT, LLC
Position in BCLI — Brainstorm Cell Therapeutics Inc.
CIK 1214717
BOSTON, MA
Position in BCLI
as of Jun 30, 2025
· filed Aug 8, 2025
Position Value
$61,131
-$12,155 QoQ
Shares Held
54,582
-6.2% QoQ
Ownership
0.495%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BCLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-06-30 | $61,131 | 54,582 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $73,286 | 58,165 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $119,176 | 52,501 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $157,047 | 682,816 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $164,656 | 484,285 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $199,942 | 357,041 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $96,401 | 357,041 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $62,155 | 310,777 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $567,954 | 275,706 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $909,829 | 275,706 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $448,877 | 273,706 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,222,731 | 276,636 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $761,508 | 275,909 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $952,509 | 283,485 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,112,404 | 278,101 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $909,975 | 275,750 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,007,524 | 265,138 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,831,728 | 478,258 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,838,831 | 405,923 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,766,409 | 399,906 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,411,381 | 393,522 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $786,874 | 169,585 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||